{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:51:47Z","timestamp":1791215507716,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.diagmicrobio.2005.10.001","type":"journal-article","created":{"date-parts":[[2005,12,19]],"date-time":"2005-12-19T18:43:01Z","timestamp":1135017781000},"page":"257-264","source":"Crossref","is-referenced-by-count":104,"title":["Prevalence and antimicrobial susceptibility data for extended-spectrum \u03b2-lactamase\u2013 and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997\u20132004)"],"prefix":"10.1016","volume":"53","author":[{"given":"Herman","family":"Goossens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Grabein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jac\/45.2.183","article-title":"Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997\u20131998","volume":"45","author":"Babini","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib2","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2005"},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1179\/joc.2002.14.4.323","article-title":"Resistance surveillance in Italy: four-year results from the MYSTIC Program","volume":"14","author":"Fontana","year":"2002","journal-title":"J. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0732-8893(00)00222-4","article-title":"Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f beta-lactamase (SME-1) in the United States: results from the MYSTIC Programme","volume":"39","author":"Gales","year":"2001","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1179\/joc.2002.14.1.25","article-title":"Antimicrobial resistance in Gram-negative isolates from European intensive care units: data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme","volume":"14","author":"Garcia-Rodriguez","year":"2002","journal-title":"J. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1469-0691.2004.00957.x","article-title":"Results of two worldwide surveys into physician awareness and perceptions of extended-spectrum beta-lactamases","volume":"10","author":"Goossens","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.idc.2004.04.003","article-title":"Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management","volume":"18","author":"Kaye","year":"2004","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/jac\/dki239","article-title":"CTX-M: changing the face of ESBLs in the UK","volume":"56","author":"Livermore","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl T2","key":"10.1016\/j.diagmicrobio.2005.10.001_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jac\/46.suppl_2.53","article-title":"Surveillance studies: how can they help the management of infection?","volume":"46","author":"Masterton","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2005.10.001_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0195-6701(03)00294-9","article-title":"Appropriate antimicrobial treatment in nosocomial infections\u2014the clinical challenges","volume":"55","author":"Masterton","year":"2003","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jac\/dkh511","article-title":"The OPTAMA Programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe","volume":"55","author":"Masterton","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1590\/S1413-86702005000100008","article-title":"Antimicrobial susceptibility in intensive care units: MYSTIC Program Brazil 2002","volume":"9","author":"Mendes","year":"2005","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/49.1.7","article-title":"Antibiotic resistance surveillance: action for international studies","volume":"49","author":"Morris","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib14","series-title":"Methods for dilution antimicrobial test for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib15","unstructured":"Paterson DL, Bonomo RA, Kolano J, et al (2002) Ertapenem resistance in extended-spectrum beta-lactamase (ESBL) producing Klebsiella pneumoniae bloodstream isolates. Program and Abstracts of the Forty-Second Interscience Conference on Antimicrobial Agents and Chemotherapy, p 118 C2-1886 (abstract)."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib16","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1128\/AAC.47.11.3554-3560.2003","article-title":"Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases","volume":"47","author":"Paterson","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0924-8579(02)00009-2","article-title":"Antimicrobial susceptibility of inducible AmpC beta-lactamase\u2013producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997\u20132000","volume":"19","author":"Pfaller","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib18","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1128\/AAC.47.9.2864-2867.2003","article-title":"Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals","volume":"47","author":"Quinteros","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib19","doi-asserted-by":"crossref","first-page":"203S","DOI":"10.1592\/phco.24.18.203S.52236","article-title":"Resistance to antimicrobial agents: An update","volume":"24","author":"Rybak","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1590\/S1413-86702001000400006","article-title":"Pathogen frequency and resistance patterns in Brazilian hospitals: Summary of results from three years of the SENTRY Antimicrobial Surveillance Program","volume":"5","author":"Sader","year":"2001","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.resmic.2004.02.009","article-title":"Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases","volume":"155","author":"Shah","year":"2004","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1086\/420937","article-title":"Trends in antimicrobial drug development: Implications for the future","volume":"38","author":"Spellberg","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl T2","key":"10.1016\/j.diagmicrobio.2005.10.001_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/46.suppl_2.9","article-title":"MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): A global overview","volume":"46","author":"Turner","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.diagmicrobio.2004.07.004","article-title":"Susceptibility of meropenem and comparators tested against 30,634 Enterobacteriaceae isolated in the MYSTIC Programme (1997\u20132003)","volume":"50","author":"Turner","year":"2004","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.diagmicrobio.2004.11.013","article-title":"Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalised in European medical centres: 6-year report of the MYSTIC surveillance study (1997\u20132002)","volume":"51","author":"Turner","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0924-8579(99)00115-6","article-title":"The MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) Programme","volume":"13","author":"Turner","year":"1999","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2005.10.001_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diagmicrobio.2004.03.001","article-title":"Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals","volume":"49","author":"Villegas","year":"2004","journal-title":"Diagn. Microbiol. Infect. Dis."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889305002518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889305002518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T13:24:57Z","timestamp":1547904297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889305002518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0732889305002518"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2005.10.001","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}